Camlin Fine Sciences Ltd
NSE:CAMLINFINE

Watchlist Manager
Camlin Fine Sciences Ltd Logo
Camlin Fine Sciences Ltd
NSE:CAMLINFINE
Watchlist
Price: 130.39 INR 2.45%
Market Cap: 21.8B INR
Have any thoughts about
Camlin Fine Sciences Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Camlin Fine Sciences Ltd

Current Assets 10B
Cash & Short-Term Investments 945.1m
Receivables 3.7B
Other Current Assets 5.4B
Non-Current Assets 9.5B
Long-Term Investments 78.8m
PP&E 8B
Intangibles 598.9m
Other Non-Current Assets 809.6m
Current Liabilities 7.3B
Accounts Payable 3.2B
Accrued Liabilities 95.8m
Short-Term Debt 2.3B
Other Current Liabilities 1.6B
Non-Current Liabilities 3.5B
Long-Term Debt 3.5B
Other Non-Current Liabilities 48.2m

Balance Sheet
Camlin Fine Sciences Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
90
80
207
385
532
524
756
1 078
937
803
Cash
90
80
207
385
347
524
603
862
937
803
Cash Equivalents
0
0
0
0
185
0
153
216
0
0
Short-Term Investments
0
0
117
1 081
439
0
452
210
14
10
Total Receivables
1 180
1 668
1 508
2 150
2 231
2 641
2 793
3 537
3 937
3 656
Accounts Receivables
1 134
1 575
1 449
2 053
2 093
2 528
2 707
2 997
3 046
2 852
Other Receivables
46
93
59
97
138
113
86
541
891
804
Inventory
1 404
1 784
2 049
2 440
2 975
3 101
3 362
3 797
5 745
5 262
Other Current Assets
313
267
313
601
547
484
586
313
243
276
Total Current Assets
2 987
3 799
4 194
6 655
6 725
6 750
7 947
8 935
10 878
10 007
PP&E Net
960
1 509
1 592
2 195
2 628
4 132
5 367
7 403
8 344
8 023
PP&E Gross
960
0
1 592
2 195
2 628
4 132
5 367
7 403
8 344
8 023
Accumulated Depreciation
1 765
0
102
546
713
1 061
1 481
1 894
2 503
3 340
Intangible Assets
132
124
93
255
222
249
241
232
134
128
Goodwill
0
0
379
446
444
444
444
528
528
471
Note Receivable
39
21
53
45
247
183
286
147
42
48
Long-Term Investments
11
32
92
94
93
94
94
249
246
79
Other Long-Term Assets
167
186
322
474
509
489
436
507
429
761
Other Assets
0
0
379
446
444
444
444
528
528
471
Total Assets
4 297
N/A
5 670
+32%
6 725
+19%
10 165
+51%
10 868
+7%
12 341
+14%
14 816
+20%
18 001
+21%
20 601
+14%
19 517
-5%
Liabilities
Accounts Payable
1 066
941
784
1 778
1 646
1 737
1 584
2 338
2 884
3 246
Accrued Liabilities
16
5
14
16
11
10
3
7
0
96
Short-Term Debt
1 210
2 311
2 699
2 468
2 444
2 781
2 169
2 350
3 715
2 335
Current Portion of Long-Term Debt
110
132
96
158
229
393
514
60
66
997
Other Current Liabilities
214
215
263
289
274
557
506
1 198
1 265
649
Total Current Liabilities
2 615
3 604
3 857
4 709
4 604
5 478
4 776
5 953
7 930
7 323
Long-Term Debt
281
214
513
1 102
1 936
2 212
2 817
4 047
4 224
3 499
Deferred Income Tax
37
22
31
0
1
21
63
103
151
68
Minority Interest
0
0
176
622
594
570
697
171
47
78
Other Liabilities
15
19
21
20
24
29
28
248
55
58
Total Liabilities
2 948
N/A
3 859
+31%
4 599
+19%
6 453
+40%
7 159
+11%
8 309
+16%
8 382
+1%
10 521
+26%
12 407
+18%
10 870
-12%
Equity
Common Stock
96
97
104
121
121
121
127
157
157
167
Retained Earnings
1 219
1 587
1 393
1 316
1 263
1 627
2 587
2 538
3 223
2 596
Additional Paid In Capital
80
107
681
2 145
2 146
2 146
2 439
3 819
3 827
4 902
Unrealized Security Profit/Loss
0
0
0
0
0
0
1 002
826
638
449
Other Equity
47
20
52
130
178
136
278
262
492
533
Total Equity
1 349
N/A
1 811
+34%
2 126
+17%
3 712
+75%
3 709
0%
4 031
+9%
6 434
+60%
7 479
+16%
8 194
+10%
8 648
+6%
Total Liabilities & Equity
4 297
N/A
5 670
+32%
6 725
+19%
10 165
+51%
10 868
+7%
12 341
+14%
14 816
+20%
18 001
+21%
20 601
+14%
19 517
-5%
Shares Outstanding
Common Shares Outstanding
96
97
104
121
121
121
127
157
157
167

See Also

Discover More